Talking about recommended age or fewer doses: what motivates HPV vaccination timeliness?

HPV vaccination is recommended for U.S. adolescents at ages 11-12 and requires two versus three doses if the series is started before age 15. We evaluated how talking about recommended age or fewer doses motivates on-time HPV vaccination. Our national, online experiment randomized 1,263 parents of a...

Full description

Saved in:
Bibliographic Details
Published in:Human vaccines & immunotherapeutics 2021-09, Vol.17 (9), p.3077-3080
Main Authors: Margolis, Marjorie A, Brewer, Noel T, Shah, Parth D, Calo, William A, Alton Dailey, Susan, Gilkey, Melissa B
Format: Article
Language:English
Subjects:
Adolescent
adolescent health
Child
Health Knowledge, Attitudes, Practice
human papillomavirus infections/prevention & control
human papillomavirus vaccine
Humans
Papillomavirus Infections - prevention & control
Papillomavirus Vaccines
Parents
patient-provider communication
Short Report
Vaccination
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c477t-ad838283aaf7481a6c139cbe80c91f48ed0482e8f196bdb3aae421dd394c17df3
cites cdi_FETCH-LOGICAL-c477t-ad838283aaf7481a6c139cbe80c91f48ed0482e8f196bdb3aae421dd394c17df3
container_end_page 3080
container_issue 9
container_start_page 3077
container_title Human vaccines & immunotherapeutics
container_volume 17
creator Margolis, Marjorie A
Brewer, Noel T
Shah, Parth D
Calo, William A
Alton Dailey, Susan
Gilkey, Melissa B
description HPV vaccination is recommended for U.S. adolescents at ages 11-12 and requires two versus three doses if the series is started before age 15. We evaluated how talking about recommended age or fewer doses motivates on-time HPV vaccination. Our national, online experiment randomized 1,263 parents of adolescents to view one of three messages about HPV vaccination recommendations or no message. Messages framed guidelines as recommending: vaccination at age 11-12; fewer doses for those who start vaccination at age 11-12; or, fewer doses for those who start vaccination before age 15. We then assessed parents' preferred age for HPV vaccination, categorizing preferences of ≤12 years as on-time. Parents who viewed "at age 11-12" versus no message more often preferred on-time HPV vaccination (63% vs. 43%,  .05). Parents who viewed "fewer doses before age 15" less often preferred on-time HPV vaccination (39%,
doi_str_mv 10.1080/21645515.2021.1912550
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_1ef1d01cca6a4097893569a7f75366b1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_1ef1d01cca6a4097893569a7f75366b1</doaj_id><sourcerecordid>2524356238</sourcerecordid><originalsourceid>FETCH-LOGICAL-c477t-ad838283aaf7481a6c139cbe80c91f48ed0482e8f196bdb3aae421dd394c17df3</originalsourceid><addsrcrecordid>eNpVkU1v1DAQhiMEolXpTwD5yGW3Hn_F4QBCFbSVKsGhoN6siT3ZuiRxsbNb8e_JstsV9cXW-J1nbD1V9Rb4ErjlZwKM0hr0UnABS2hAaM1fVMfb-kJrdfvycAZ9VJ2Wcs_nVXOhjHldHUnZGNCyOa5ub7D_FccVwzatJ5bJp2GgMVBguCKWMuvokTILqVD5wB7vcGJDmuIGJyrs8vtPtkHv44hTTCOb4kB9HKmUT2-qVx32hU73-0n14-uXm_PLxfW3i6vzz9cLr-p6WmCw0gorEbtaWUDjQTa-Jct9A52yFLiygmwHjWlDO-dICQhBNspDHTp5Ul3tuCHhvXvIccD8xyWM7l8h5ZXDPEXfkwPqIHDwHg0q3tS2kdo0WHe1lsa0MLM-7lgP63ag4GmcMvbPoM9vxnjnVmnj5j-A5XIGvN8Dcvq9pjK5IRZPfY8jpXVxQgs1zxTSzlG9i_qcSsnUHcYAd1vJ7kmy20p2e8lz37v_33joelIq_wLcU6MV</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2524356238</pqid></control><display><type>article</type><title>Talking about recommended age or fewer doses: what motivates HPV vaccination timeliness?</title><source>PubMed Central</source><creator>Margolis, Marjorie A ; Brewer, Noel T ; Shah, Parth D ; Calo, William A ; Alton Dailey, Susan ; Gilkey, Melissa B</creator><creatorcontrib>Margolis, Marjorie A ; Brewer, Noel T ; Shah, Parth D ; Calo, William A ; Alton Dailey, Susan ; Gilkey, Melissa B</creatorcontrib><description>HPV vaccination is recommended for U.S. adolescents at ages 11-12 and requires two versus three doses if the series is started before age 15. We evaluated how talking about recommended age or fewer doses motivates on-time HPV vaccination. Our national, online experiment randomized 1,263 parents of adolescents to view one of three messages about HPV vaccination recommendations or no message. Messages framed guidelines as recommending: vaccination at age 11-12; fewer doses for those who start vaccination at age 11-12; or, fewer doses for those who start vaccination before age 15. We then assessed parents' preferred age for HPV vaccination, categorizing preferences of ≤12 years as on-time. Parents who viewed "at age 11-12" versus no message more often preferred on-time HPV vaccination (63% vs. 43%, &lt; .05) and did not differ from those viewing "fewer doses at age 11-12" (63% vs. 64%, &gt; .05). Parents who viewed "fewer doses before age 15" less often preferred on-time HPV vaccination (39%, &lt; .05). Recommending HPV vaccination at age 11-12 encouraged on-time vaccination, while offering fewer doses had little impact. Providers should avoid framing HPV vaccination guidelines in reference to age 15 because doing so may discourage on-time vaccination by introducing confusion about the recommended age.</description><identifier>ISSN: 2164-5515</identifier><identifier>EISSN: 2164-554X</identifier><identifier>DOI: 10.1080/21645515.2021.1912550</identifier><identifier>PMID: 33961539</identifier><language>eng</language><publisher>United States: Taylor &amp; Francis</publisher><subject>Adolescent ; adolescent health ; Child ; Health Knowledge, Attitudes, Practice ; human papillomavirus infections/prevention &amp; control ; human papillomavirus vaccine ; Humans ; Papillomavirus Infections - prevention &amp; control ; Papillomavirus Vaccines ; Parents ; patient-provider communication ; Short Report ; Vaccination</subject><ispartof>Human vaccines &amp; immunotherapeutics, 2021-09, Vol.17 (9), p.3077-3080</ispartof><rights>2021 Taylor &amp; Francis Group, LLC 2021 Taylor &amp; Francis</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c477t-ad838283aaf7481a6c139cbe80c91f48ed0482e8f196bdb3aae421dd394c17df3</citedby><cites>FETCH-LOGICAL-c477t-ad838283aaf7481a6c139cbe80c91f48ed0482e8f196bdb3aae421dd394c17df3</cites><orcidid>0000-0003-2241-7002 ; 0000-0001-8452-5063 ; 0000-0002-3536-6219 ; 0000-0003-4801-8579</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381803/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381803/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33961539$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Margolis, Marjorie A</creatorcontrib><creatorcontrib>Brewer, Noel T</creatorcontrib><creatorcontrib>Shah, Parth D</creatorcontrib><creatorcontrib>Calo, William A</creatorcontrib><creatorcontrib>Alton Dailey, Susan</creatorcontrib><creatorcontrib>Gilkey, Melissa B</creatorcontrib><title>Talking about recommended age or fewer doses: what motivates HPV vaccination timeliness?</title><title>Human vaccines &amp; immunotherapeutics</title><addtitle>Hum Vaccin Immunother</addtitle><description>HPV vaccination is recommended for U.S. adolescents at ages 11-12 and requires two versus three doses if the series is started before age 15. We evaluated how talking about recommended age or fewer doses motivates on-time HPV vaccination. Our national, online experiment randomized 1,263 parents of adolescents to view one of three messages about HPV vaccination recommendations or no message. Messages framed guidelines as recommending: vaccination at age 11-12; fewer doses for those who start vaccination at age 11-12; or, fewer doses for those who start vaccination before age 15. We then assessed parents' preferred age for HPV vaccination, categorizing preferences of ≤12 years as on-time. Parents who viewed "at age 11-12" versus no message more often preferred on-time HPV vaccination (63% vs. 43%, &lt; .05) and did not differ from those viewing "fewer doses at age 11-12" (63% vs. 64%, &gt; .05). Parents who viewed "fewer doses before age 15" less often preferred on-time HPV vaccination (39%, &lt; .05). Recommending HPV vaccination at age 11-12 encouraged on-time vaccination, while offering fewer doses had little impact. Providers should avoid framing HPV vaccination guidelines in reference to age 15 because doing so may discourage on-time vaccination by introducing confusion about the recommended age.</description><subject>Adolescent</subject><subject>adolescent health</subject><subject>Child</subject><subject>Health Knowledge, Attitudes, Practice</subject><subject>human papillomavirus infections/prevention &amp; control</subject><subject>human papillomavirus vaccine</subject><subject>Humans</subject><subject>Papillomavirus Infections - prevention &amp; control</subject><subject>Papillomavirus Vaccines</subject><subject>Parents</subject><subject>patient-provider communication</subject><subject>Short Report</subject><subject>Vaccination</subject><issn>2164-5515</issn><issn>2164-554X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkU1v1DAQhiMEolXpTwD5yGW3Hn_F4QBCFbSVKsGhoN6siT3ZuiRxsbNb8e_JstsV9cXW-J1nbD1V9Rb4ErjlZwKM0hr0UnABS2hAaM1fVMfb-kJrdfvycAZ9VJ2Wcs_nVXOhjHldHUnZGNCyOa5ub7D_FccVwzatJ5bJp2GgMVBguCKWMuvokTILqVD5wB7vcGJDmuIGJyrs8vtPtkHv44hTTCOb4kB9HKmUT2-qVx32hU73-0n14-uXm_PLxfW3i6vzz9cLr-p6WmCw0gorEbtaWUDjQTa-Jct9A52yFLiygmwHjWlDO-dICQhBNspDHTp5Ul3tuCHhvXvIccD8xyWM7l8h5ZXDPEXfkwPqIHDwHg0q3tS2kdo0WHe1lsa0MLM-7lgP63ag4GmcMvbPoM9vxnjnVmnj5j-A5XIGvN8Dcvq9pjK5IRZPfY8jpXVxQgs1zxTSzlG9i_qcSsnUHcYAd1vJ7kmy20p2e8lz37v_33joelIq_wLcU6MV</recordid><startdate>20210902</startdate><enddate>20210902</enddate><creator>Margolis, Marjorie A</creator><creator>Brewer, Noel T</creator><creator>Shah, Parth D</creator><creator>Calo, William A</creator><creator>Alton Dailey, Susan</creator><creator>Gilkey, Melissa B</creator><general>Taylor &amp; Francis</general><general>Taylor &amp; Francis Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-2241-7002</orcidid><orcidid>https://orcid.org/0000-0001-8452-5063</orcidid><orcidid>https://orcid.org/0000-0002-3536-6219</orcidid><orcidid>https://orcid.org/0000-0003-4801-8579</orcidid></search><sort><creationdate>20210902</creationdate><title>Talking about recommended age or fewer doses: what motivates HPV vaccination timeliness?</title><author>Margolis, Marjorie A ; Brewer, Noel T ; Shah, Parth D ; Calo, William A ; Alton Dailey, Susan ; Gilkey, Melissa B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c477t-ad838283aaf7481a6c139cbe80c91f48ed0482e8f196bdb3aae421dd394c17df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adolescent</topic><topic>adolescent health</topic><topic>Child</topic><topic>Health Knowledge, Attitudes, Practice</topic><topic>human papillomavirus infections/prevention &amp; control</topic><topic>human papillomavirus vaccine</topic><topic>Humans</topic><topic>Papillomavirus Infections - prevention &amp; control</topic><topic>Papillomavirus Vaccines</topic><topic>Parents</topic><topic>patient-provider communication</topic><topic>Short Report</topic><topic>Vaccination</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Margolis, Marjorie A</creatorcontrib><creatorcontrib>Brewer, Noel T</creatorcontrib><creatorcontrib>Shah, Parth D</creatorcontrib><creatorcontrib>Calo, William A</creatorcontrib><creatorcontrib>Alton Dailey, Susan</creatorcontrib><creatorcontrib>Gilkey, Melissa B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Human vaccines &amp; immunotherapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Margolis, Marjorie A</au><au>Brewer, Noel T</au><au>Shah, Parth D</au><au>Calo, William A</au><au>Alton Dailey, Susan</au><au>Gilkey, Melissa B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Talking about recommended age or fewer doses: what motivates HPV vaccination timeliness?</atitle><jtitle>Human vaccines &amp; immunotherapeutics</jtitle><addtitle>Hum Vaccin Immunother</addtitle><date>2021-09-02</date><risdate>2021</risdate><volume>17</volume><issue>9</issue><spage>3077</spage><epage>3080</epage><pages>3077-3080</pages><issn>2164-5515</issn><eissn>2164-554X</eissn><abstract>HPV vaccination is recommended for U.S. adolescents at ages 11-12 and requires two versus three doses if the series is started before age 15. We evaluated how talking about recommended age or fewer doses motivates on-time HPV vaccination. Our national, online experiment randomized 1,263 parents of adolescents to view one of three messages about HPV vaccination recommendations or no message. Messages framed guidelines as recommending: vaccination at age 11-12; fewer doses for those who start vaccination at age 11-12; or, fewer doses for those who start vaccination before age 15. We then assessed parents' preferred age for HPV vaccination, categorizing preferences of ≤12 years as on-time. Parents who viewed "at age 11-12" versus no message more often preferred on-time HPV vaccination (63% vs. 43%, &lt; .05) and did not differ from those viewing "fewer doses at age 11-12" (63% vs. 64%, &gt; .05). Parents who viewed "fewer doses before age 15" less often preferred on-time HPV vaccination (39%, &lt; .05). Recommending HPV vaccination at age 11-12 encouraged on-time vaccination, while offering fewer doses had little impact. Providers should avoid framing HPV vaccination guidelines in reference to age 15 because doing so may discourage on-time vaccination by introducing confusion about the recommended age.</abstract><cop>United States</cop><pub>Taylor &amp; Francis</pub><pmid>33961539</pmid><doi>10.1080/21645515.2021.1912550</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0003-2241-7002</orcidid><orcidid>https://orcid.org/0000-0001-8452-5063</orcidid><orcidid>https://orcid.org/0000-0002-3536-6219</orcidid><orcidid>https://orcid.org/0000-0003-4801-8579</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2164-5515
ispartof Human vaccines & immunotherapeutics, 2021-09, Vol.17 (9), p.3077-3080
issn 2164-5515
2164-554X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_1ef1d01cca6a4097893569a7f75366b1
source PubMed Central
subjects Adolescent
adolescent health
Child
Health Knowledge, Attitudes, Practice
human papillomavirus infections/prevention & control
human papillomavirus vaccine
Humans
Papillomavirus Infections - prevention & control
Papillomavirus Vaccines
Parents
patient-provider communication
Short Report
Vaccination
title Talking about recommended age or fewer doses: what motivates HPV vaccination timeliness?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-22T23%3A39%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Talking%20about%20recommended%20age%20or%20fewer%20doses:%20what%20motivates%20HPV%20vaccination%20timeliness?&rft.jtitle=Human%20vaccines%20&%20immunotherapeutics&rft.au=Margolis,%20Marjorie%20A&rft.date=2021-09-02&rft.volume=17&rft.issue=9&rft.spage=3077&rft.epage=3080&rft.pages=3077-3080&rft.issn=2164-5515&rft.eissn=2164-554X&rft_id=info:doi/10.1080/21645515.2021.1912550&rft_dat=%3Cproquest_doaj_%3E2524356238%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c477t-ad838283aaf7481a6c139cbe80c91f48ed0482e8f196bdb3aae421dd394c17df3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2524356238&rft_id=info:pmid/33961539&rfr_iscdi=true